Ubs Group Ag Amerisourcebergen Corp Call Options Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	54,000 Added 5400.0%	55,000 $10.2 Million
Q1 2024 May 13, 2024	BUY	N/A	1,000 New	1,000 $185,000
Q1 2020 May 01, 2020	SELL	$73.93 - $97.0 $539,689 - $708,100	-7,300 Reduced 85.88%	1,200 $106,000
Q4 2019 Feb 14, 2020	SELL	$80.17 - $90.64 $56,119 - $63,448	-700 Reduced 7.61%	8,500 $723,000
Q1 2019 May 14, 2019	SELL	$73.37 - $86.85 $550,275 - $651,375	-7,500 Reduced 44.91%	9,200 $732,000
Q4 2018 Feb 14, 2019	BUY	$70.76 - $93.76 $134,444 - $178,144	1,900 Added 12.84%	16,700 $1.24 Million
Q4 2017 Feb 14, 2018	SELL	$73.23 - $93.79 $7.72 Million - $9.89 Million	-105,400 Reduced 87.69%	14,800 $1.36 Million
Q1 2017 Nov 14, 2017	BUY	N/A	120,200	120,200 $10.6 Million

1,264

168M

7.52M

6.12M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.